Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family
Year: 2005
Type: article
Source: International Immunopharmacology
Authors: Masahiko Mihara, Keiko Kasutani, Makoto Okazaki, Akito Nakamura, Shigeto Kawai, Masamichi Sugimoto, Yoshihiro Matsumoto, Yoshiyuki Ohsugi
Institution: Chugai Pharmaceutical Co., Ltd. (Japan)
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1987192197